![Long-term safety and efficacy of alirocumab in patients with heterozygous familial hypercholesterolemia: An open-label extension of the ODYSSEY program - ScienceDirect Long-term safety and efficacy of alirocumab in patients with heterozygous familial hypercholesterolemia: An open-label extension of the ODYSSEY program - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0021915018313455-gr1.jpg)
Long-term safety and efficacy of alirocumab in patients with heterozygous familial hypercholesterolemia: An open-label extension of the ODYSSEY program - ScienceDirect
![An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis | Arthritis Research & Therapy | Full Text An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis | Arthritis Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13075-019-1857-3/MediaObjects/13075_2019_1857_Fig1_HTML.png)
An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis | Arthritis Research & Therapy | Full Text
![Long‐term cannabidiol treatment in patients with Dravet syndrome: An open‐label extension trial - Devinsky - 2019 - Epilepsia - Wiley Online Library Long‐term cannabidiol treatment in patients with Dravet syndrome: An open‐label extension trial - Devinsky - 2019 - Epilepsia - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/8ecc2a92-57cb-42bb-bdd4-9c85e9c38f15/epi14628-fig-0001-m.jpg)
Long‐term cannabidiol treatment in patients with Dravet syndrome: An open‐label extension trial - Devinsky - 2019 - Epilepsia - Wiley Online Library
![Flow chart showing the study design of the open-label extension phase... | Download Scientific Diagram Flow chart showing the study design of the open-label extension phase... | Download Scientific Diagram](https://www.researchgate.net/publication/337470199/figure/fig2/AS:836912487088133@1576546894872/Flow-chart-showing-the-study-design-of-the-open-label-extension-phase-OLE-of-the_Q640.jpg)
Flow chart showing the study design of the open-label extension phase... | Download Scientific Diagram
![Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial - The Lancet Rheumatology Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial - The Lancet Rheumatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/10cfb42a-cd7b-4a5d-bc3a-0cb46a2046e3/gr2.jpg)
Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial - The Lancet Rheumatology
![Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial - The Lancet Neurology Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial - The Lancet Neurology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2883e24f-ded5-4447-96b4-db02193741ca/gr1.gif)
Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial - The Lancet Neurology
![Study design schematic for the open-label extension study. AE, adverse... | Download Scientific Diagram Study design schematic for the open-label extension study. AE, adverse... | Download Scientific Diagram](https://www.researchgate.net/profile/Herbert-Baraf/publication/233396586/figure/fig4/AS:289187577253918@1445959099647/Figure1-Study-design-schematic-for-the-open-label-extension-study-AE-adverse-event-IR.png)
Study design schematic for the open-label extension study. AE, adverse... | Download Scientific Diagram
![InflaRx Reports Positive Results from the Open Label Extension Part of the SHINE Study for IFX-1 in Hidradenitis Suppurativa | Markets Insider InflaRx Reports Positive Results from the Open Label Extension Part of the SHINE Study for IFX-1 in Hidradenitis Suppurativa | Markets Insider](https://www.accesswire.com/users/newswire/images/565611/image-20191107020335-1.png)
InflaRx Reports Positive Results from the Open Label Extension Part of the SHINE Study for IFX-1 in Hidradenitis Suppurativa | Markets Insider
![A phase 2/3 randomized clinical trial followed by an open-label extension to evaluate the effectiveness of elamipretide in Barth syndrome, a genetic disorder of mitochondrial cardiolipin metabolism | Genetics in Medicine A phase 2/3 randomized clinical trial followed by an open-label extension to evaluate the effectiveness of elamipretide in Barth syndrome, a genetic disorder of mitochondrial cardiolipin metabolism | Genetics in Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41436-020-01006-8/MediaObjects/41436_2020_1006_Fig1_HTML.png)
A phase 2/3 randomized clinical trial followed by an open-label extension to evaluate the effectiveness of elamipretide in Barth syndrome, a genetic disorder of mitochondrial cardiolipin metabolism | Genetics in Medicine
![How to process data from clinical trials and their open label extensions PhUSE, Berlin, October 2010 Thomas Grupe and Stephanie Bartsch, Clinical Data. - ppt download How to process data from clinical trials and their open label extensions PhUSE, Berlin, October 2010 Thomas Grupe and Stephanie Bartsch, Clinical Data. - ppt download](https://images.slideplayer.com/23/6590870/slides/slide_3.jpg)
How to process data from clinical trials and their open label extensions PhUSE, Berlin, October 2010 Thomas Grupe and Stephanie Bartsch, Clinical Data. - ppt download
![Randomized controlled trial and open-label extension study designs.... | Download Scientific Diagram Randomized controlled trial and open-label extension study designs.... | Download Scientific Diagram](https://www.researchgate.net/profile/Wendy-Komocsar/publication/265174624/figure/fig1/AS:267323823095810@1440746374062/Randomized-controlled-trial-and-open-label-extension-study-designs-aNonresponders-20.png)
Randomized controlled trial and open-label extension study designs.... | Download Scientific Diagram
![Long-term safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis: results from the open-label extension study, INPULSIS-ON - The Lancet Respiratory Medicine Long-term safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis: results from the open-label extension study, INPULSIS-ON - The Lancet Respiratory Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/cfac1a35-6189-40e5-a837-3198781589e2/gr1.gif)
Long-term safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis: results from the open-label extension study, INPULSIS-ON - The Lancet Respiratory Medicine
![Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study - The Lancet Respiratory Medicine Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study - The Lancet Respiratory Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/09b4693d-be29-4706-bb5a-934e3a7910fd/gr1.jpg)
Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study - The Lancet Respiratory Medicine
![Design of the lurasidone open-label core and extension switch studies.*... | Download Scientific Diagram Design of the lurasidone open-label core and extension switch studies.*... | Download Scientific Diagram](https://www.researchgate.net/publication/303715017/figure/fig1/AS:560604952711171@1510670044939/Design-of-the-lurasidone-open-label-core-and-extension-switch-studies-144-of-the-235.png)